Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2024 | The impact of SETD2 loss on CML progression

Simona Soverini • 5 Sep 2024
SOHO 2024
Chronic Myeloid Leukemia Leukemia

Simona Soverini, PhD, University of Bologna, Bologna, Italy, discusses research initiated by whole exome sequencing of a patient who progressed from chronic phase to blast crisis in chronic myeloid leukemia (CML). The research revealed that loss of function in the SETD2 gene is common in advanced phase CML, often caused by enhanced degradation via the proteasome system. This interview took place at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024) congress in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Simona Soverini

An analysis of the impact of ASXL1 mutations in patients with CP-CML treated in the SUSTRENIM trial 3:54
An analysis of the impact of ASXL1 mutations in patients with CP-CML treated in the SUSTRENIM trial
Simona Soverini • 7 Dec 2024
Novel agents in development for the treatment of CML 1:32
Novel agents in development for the treatment of CML
Simona Soverini • 7 Dec 2024
Guidance on mutational testing for diagnosing and monitoring CML 2:14
Guidance on mutational testing for diagnosing and monitoring CML
Simona Soverini • 5 Sep 2024
Essential diagnostic tests for CML: cytogenetics, FISH, and PCR 2:09
Essential diagnostic tests for CML: cytogenetics, FISH, and PCR
Simona Soverini • 5 Sep 2024

Related Videos

The value and mission of the International Workshop on Acute Leukemias 14:36
The value and mission of the International Workshop on Acute Leukemias
Charles Craddock et al. • 21 Oct 2025
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years? 1:30
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years?
Koichi Takahashi • 26 Sep 2025
One big question with Naval Daver: what AML advance could transform frontline care in three years? 1:05
One big question with Naval Daver: what AML advance could transform frontline care in three years?
Naval Daver • 26 Sep 2025
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years? 3:13
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years?
Charles Craddock • 26 Sep 2025
The content of VJHemOnc is intended for healthcare professionals